Promiscuity and Selectivity in Covalent Enzyme Inhibition: A Systematic Study of Electrophilic Fragments
作者:Christian Jöst、Christoph Nitsche、Therese Scholz、Lionel Roux、Christian D. Klein
DOI:10.1021/jm5006918
日期:2014.9.25
building blocks for covalently binding ligands. Six reactive groups with modulated electrophilicity were combined with 11 nonreactive moieties, resulting in a small combinatoriallibrary of 72 fragment-like compounds. These compounds were screened against a group of 11 enzyme targets to assess their selectivity and their potential for promiscuous binding to proteins. The assay results showed a considerably
A shade enhancing agent comprises an aqueous resin emulsion composition obtained by polymerizing a monomer in the presence of a cationic surfactant or a cationic protective colloid, polymerizing a monomer and adding a cationic protective colloid or polymerizing a monomer in the presence of a cationic or nonionic emulsifying dispersant so as to have a cationic group in the molecule, a dry film of said composition having a glass transition point (Tg) in the range between 20°c and 110°c and a refractive index of 1.50 or less, said emulsion composition having a zeta potential in the range between +5 and +80 mV at an ion strength of 10-3 and a pH value of 7.
Method for manufacturing binder for lead storage battery glass mats
申请人:National Starch and Chemical Investment
Holding Corporation
公开号:EP0381077A2
公开(公告)日:1990-08-08
A method for manufacturing binder for lead storage battery glass mats, characterized in that the ingredients (A) and (B) below are mixed and emulsion-polymerized:
(A) an aqueous dispersion obtained by mixing the following raw materials; (a) a thermo-crosslinking monomer and (b) an alkyl (meth)acrylate ester, as necessary ingredients, and emulsion-polymerizing them;
(B) a monomer mixture of a polymerizable unsaturated carboxylic acid (c) and the alkyl (meth)acrylate ester, as necessary ingredients.
Benzylpyrrolidine derivatives as dopamine agonists
申请人:SYNTEX (U.S.A.) INC.
公开号:EP0426075A1
公开(公告)日:1991-05-08
Dopamine agonist compounds disclosed are useful in treating hypertension and congestive heart failure in mammals. The compounds have the following general formula (I)
wherein:
R is hydrogen or lower alkyl;
each R1 is independently hydrogen,
or halo;
R2 is lower alkyl or optionally substituted phenyl; m is an integer of 0, 1, 2, 3, 4, 5, or 6; and n is an integer of from 1 to 10; or a pharmaceutically acceptable salt, (R) or (S) stereoisomers, or racemic or non-racemic mixtures thereof.
HEAT TRANSPIRATION PREPARATION AND METHOD OF THE HEAT TRANSPIRATION OF CHEMICAL BY USING THE SAME
申请人:Earth Chemical Co., Ltd.
公开号:EP1065252A1
公开(公告)日:2001-01-03
To provide thermal evaporation preparations and a method of thermal evaporating chemicals whereby the chemicals can be efficiently evaporated.
Thermal evaporation preparations, wherein the preparation is in the form of a solid at ordinary temperature but molten by heating into a liquid as a whole, and a chemical employed as the active ingredient is evaporated from the ingredients of the preparation thus liquefied by heating, and a method of thermal evaporating chemicals.